COVID-19 Real Time Learning Network

The Latest: What You Need to Know

NIH Updates Guidance for Ritonavir-Boosted Nirmatrelvir to Treat COVID-19

NIH updated its guidelines for the use of ritonavir-boosted nirmatrelvir (Paxlovid) to reflect the latest information on recurrent COVID-19 symptoms and drug-drug interactions.

VISIT WEBSITE

13 May, 2022

NIH: Prioritization of Anti-SARS-CoV-2 Therapies for Treatment and Prevention of COVID-19 in Cases of Logistical or Supply Constraints

COVID-19 therapeutic prioritization should be used only during logistical or supply constraints; when there are no constraints, the NIH Guidelines Panel recommends that prevention/treatment therapies be prescribed for any eligible individual.

VISIT WEBSITE

13 May, 2022

IDSA Revises Recommendation on Use of Baricitinib with Corticosteroids for Treating COVID-19

Among hospitalized adults with severe COVID-19, IDSA suggests using baricitinib in combination with corticosteroids.

VISIT WEBSITE

10 May, 2022

CDC/IDSA COVID-19 Clinician Call: Antibody Therapy & Second Boosters

Recording of video call focusing on Evusheld for post-exposure prophylaxis, monoclonal antibody treatment and second boosters in high-risk individuals.

PLAY MEDIA

9 May, 2022

IDSA Releases Guide for Managing Paxlovid Drug Interactions

This new resource (released May 6) provides steps to minimize risk of interactions and emphasizes that giving nirmatrelvir/ritonavir (Paxlovid®) with most commonly prescribed medications can be managed and is not contraindicated.

VISIT WEBSITE

6 May, 2022

Vaccine Education Roundtable Series: The Future of Minoritized Communities in the COVID-19 Pandemic – Strategies to Drive Equity

Video recording of panel on policies and strategies to address the disproportionate impact COVID-19 has had on minoritized communities and how health care providers can drive health equity in these communities.

PLAY MEDIA

5 May, 2022

Featured Resources

IDSA/CDC COVID-19 Clinician Call

CDC Clinician Hotline

Clinicians are waiting on standby to answer your COVID-19 questions. Dial 1-800-CDC-INFO.

Podcast

IDSA's COVID-19: What's Happening Now podcast keeps listeners informed with expert analysis.

Events

Our directory of digital/virtual events and learning opportunities for the COVID-19 Real-Time Learning Network community.

Shareable Resources

Pregnancy and the COVID-19 Vaccine

Tixagevimab & Cilgavimab (Evusheld™) Point-of-Care Reference

COVID-19 Outpatient Treatment Guidelines Roadmap

Molnupiravir Quick Point-of-Care Reference

COVID-19, Myocarditis, and Vaccines

Long COVID Patient Fact Sheet

Nirmatrelvir/Ritonavir (Paxlovid™) Point-of-Care Reference

Ivermectin & COVID-19

COVID-19 Variants

Pregnancy & COVID-19

Latest Multimedia

Cultural Awareness Series: Asian American and Pacific Islander Heritage Month, Part 2 — Addressing Workforce Barriers to Achieve Equitable Representation in Health Care

5/12/2022

CDC/IDSA COVID-19 Clinician Call: Antibody Therapy & Second Boosters: Updates and Perspectives on Protecting Our Most Vulnerable

5/9/2022

Vaccine Education Roundtable Series: The Future of Minoritized Communities in the COVID-19 Pandemic, Part 2 – Strategies to Drive Equity

5/5/2022

Cultural Awareness Series: Asian American and Pacific Islander Heritage Month, Part 2 — Addressing Workforce Barriers to Achieve Equitable Representation in Health Care

5/12/2022

CDC/IDSA COVID-19 Clinician Call: Antibody Therapy & Second Boosters: Updates and Perspectives on Protecting Our Most Vulnerable

5/9/2022

Vaccine Education Roundtable Series: The Future of Minoritized Communities in the COVID-19 Pandemic, Part 2 – Strategies to Drive Equity

5/5/2022

About the COVID-19 Real-Time Learning Network

The COVID-19 Real-Time Learning Network is a curated repository of clinical guidance, emerging research, and practice management tools to support clinicians of all backgrounds. With funding from the Centers for Disease Control and Prevention and guidance from a multidisciplinary Advisory Group, this site is updated daily with must-have information for clinicians and decision-makers.